Anbio Biotechnology (NASDAQ:NNNN) Trading Up 6.7% – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s share price was up 6.7% during trading on Wednesday . The company traded as high as $17.26 and last traded at $17.25. Approximately 8,704 shares were traded during trading, a decline of 80% from the average daily volume of 43,359 shares. The stock had previously closed at $16.16.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Anbio Biotechnology Price Performance

The company has a 50 day moving average price of $27.66.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.